Docteur EL ALI Ziad Oncologie Médicale
0745.761.932 · rovalta.com · 28/09/2026
ACTIVE
Docteur EL ALI Ziad Oncologie Médicale
Financial year 2025 · Closed on 31/12/2025
Net result60,2 k €+12,1 %over 1 year
Gross margin125,8 k €+7,1 %over 1 year
Equity127,7 k €-30,0 %over 1 year
Overview
Identity
Source · BCE/KBODocteur EL ALI Ziad Oncologie Médicale is a Private limited company incorporated in 2020. Its registered office is in Bruxelles.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0745.761.932
- Incorporation
- 01/04/2020
- Legal form
- Private limited company
- Registered office
- Square Marie-Louise 18 box 12
1000 Bruxelles · BruxellesSee on map - Latest accounts
- 31/12/2025
Signals
ProfitableSolid equityLow riskPositive cashflowPositive EBITDA
Financials
Source · NBB, 6 filingsTrend over 6 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 125,8 k € | +7.1% | 117,5 k € | +5.5% | 111,4 k € | -10.2% | 124 k € | -10.8% | 138,9 k € |
| EBITDA | 121,6 k € | +5.4% | 115,4 k € | +8.0% | 106,8 k € | -12.4% | 121,9 k € | -10.1% | 135,7 k € |
| Operating result | 78,2 k € | +10.7% | 70,7 k € | +14.4% | 61,8 k € | -25.5% | 83 k € | -15.2% | 97,9 k € |
| Net result | 60,2 k € | +12.1% | 53,7 k € | +15.2% | 46,6 k € | -19.7% | 58 k € | -16.7% | 69,7 k € |
| Balance sheet | |||||||||
| Equity | 127,7 k € | -30.0% | 182,4 k € | 0.0% | 182,4 k € | 0.0% | 182,4 k € | +46.7% | 124,4 k € |
| Total assets | 281,2 k € | -3.1% | 290,1 k € | -6.7% | 311,1 k € | -13.3% | 358,7 k € | +3.3% | 347,2 k € |
| Cash | 102,5 k € | +8.0% | 94,9 k € | +14.2% | 83,1 k € | -1.0% | 83,9 k € | +79.4% | 46,8 k € |
| Debts | 153,5 k € | +42.5% | 107,7 k € | -16.3% | 128,7 k € | -27.0% | 176,3 k € | -20.9% | 222,9 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
EL ALI ZIAD | Director |
Other companies at this address
Square Marie-Louise 18 1000 Bruxelles| Company | CBE no. |
|---|---|
| 0416.846.414 | |
| 0741.547.182 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 31/03/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 10 months |
| Filing date | 30/03/2026 | 25/08/2025 | 29/08/2024 | 31/07/2023 | 30/06/2022 | 30/08/2021 |
| General meeting | 17/03/2026 | 19/06/2025 | 20/06/2024 | 15/06/2023 | 18/06/2022 | 18/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 6 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 17/03/2026 | 30/03/2026 | French | |
| Micro model | 31/12/2024 | 19/06/2025 | 25/08/2025 | French | |
| Micro model | 31/12/2023 | 20/06/2024 | 29/08/2024 | French | |
| Micro model | 31/12/2022 | 15/06/2023 | 31/07/2023 | French | |
| Micro model | 31/12/2021 | 18/06/2022 | 30/06/2022 | French | |
| Micro model | 31/12/2020 | 18/06/2021 | 30/08/2021 | French |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
EL ALI ZIAD | Director |
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Incorporation
Name
Registered office
Annual accounts
Filings6 filings
2020202120222023202420252026
Docteur EL ALI Ziad Oncologie Médicale
Square Marie-Louise 18 bte 12, 1000 Brussels
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Square Marie-Louise 18 bte 12, 1000 BrusselsCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00066220 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Docteur EL ALI Ziad Oncologie MédicaleCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00066220 |
Events
- 2025Annual accounts 202560,2 k €↑
- 2024Annual accounts 202453,7 k €↑
- 2023Annual accounts 202346,6 k €↓
- 2022Annual accounts 202258 k €↓
- 2021Annual accounts 202169,7 k €↑
- 2020Annual accounts 202054,7 k €
- 01/04/2020IncorporationPrivate limited company